RECURSION PHARMACEUTICALS, INC.
RECURSION PHARMACEUTICALS, INC. (RXRX) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 1015 transactions totaling $125.8M, demonstrating a bullish sentiment with $3.6M in net insider flow. The most recent transaction on Feb 19, 2026 involved a transaction of 40,000 shares valued at $0.
RXRX Insider Activity Summary
Who Is Buying RXRX Stock?
No significant insider buying has been recorded for RXRX in the recent period.
Who Is Selling RXRX Stock?
No significant insider selling has been recorded for RXRX in the recent period.
Is RECURSION PHARMACEUTICALS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for RXRX is bullish with an Insider Alignment Score of 51/100 and a net flow of $3.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
RXRX Frequently Asked Questions
Understanding RXRX Insider Activity
Insider trading at RECURSION PHARMACEUTICALS, INC. (RXRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading RXRX stock, having executed 1015 transactions in the past 90 days. The most active insider is Diversified Global Holding Pjsc Mamoura (Executive), who has made 24 transactions totaling $60.0M.
Related Tools
Track RECURSION PHARMACEUTICALS, INC. Insider Activity
Get notified when executives and directors at RXRX file new Form 4 transactions